AI assistant
Novonesis AS — Director's Dealing 2025
Aug 28, 2025
3377_rns_2025-08-28_e8895c3d-e019-4819-a7a1-c03029560b1b.pdf
Director's Dealing
Open in viewerOpens in your device viewer
{0}------------------------------------------------
Trading by management and close relations of management
In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the "Market Abuse Regulation") and commission delegated regulation (EU) 1052/2016 of 8 March 2016, Novonesis reports the following transactions under ISIN DK0060336014, Novonesis (Novozymes) B shares under the symbol NSIS B.
| 1. | Details of the person discharging managerial responsibilities/person closely associated | |||
|---|---|---|---|---|
| a) | Name | Rainer Lehmann | ||
| 2. | Reason for the notification | |||
| a) | Position/status | CFO & Executive Vice President | ||
| b) | Initial notification/ Amendment |
Amendment to Company announcement No. 41, 2025. The previously disclosed transaction date was February 25, 2025. The correct transaction date is August 25, 2025. |
||
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||
| a) | Name | Novozymes A/S | ||
| b) | LEI | 529900T6WNZXD2R3JW38 | ||
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||
| a) | Description of the financial instrument, type of instrument |
B-Shares | ||
| Identification code | DK0060336014 | |||
| b) | Nature of the transaction | Purchase of shares | ||
| c) | Price(s) and volume(s) | Price(s) DKK 396.2292 |
Volume(s) 2,000 shares |
|
| d) | Aggregated information - Aggregated volume - Price |
Number of shares: 2,000 Average price, DKK: 396.2292 Transaction value, DKK: 792,458.40 |
||
| e) | Date of transaction | August 25, 2025 | ||
| f) | Place of the transaction | - Turquoise Europe - Cboe Europe Equities - European Equities (Nl) - Boerse Berlin - Nasdaq Copenhagen A/S - Aquis Exchange Europe |
August 28, 2025
Company announcement No. 42
Contact information
Investor relations
Tobias Bjorklund +45 3077 8682 [email protected]
Anders Enevoldsen +45 5350 1453 [email protected]
Katrine Spedtsberg Poulsen [email protected]
About Novonesis
Novonesis is a global leading biosolutions company transforming the way we all produce, consume and live. In more than 30 industries our biosolutions are helping companies meet their business needs and the needs of our planet. Our 10,000 people worldwide work closely with our partners and customers to challenge conventional thinking and transform business with biology.
Novozymes A/S, part of Novonesis Group Krogshoejvej 36 2880 Bagsvaerd Denmark